Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

In this Discussion

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

Biotechs Beating The Market, But Are They In Buy Range?

FYI: Biotechs continue to outmuscle the broader stock market as both nonleveraged and leveraged exchange traded funds are showing healthy gains.
Regards,
Ted
http://www.investors.com/etfs-and-funds/etfs/biotech-stocks-beating-the-stock-market-but-are-they-in-buy-range/

Comments

  • In the linked article, I found that the graphs' red line must be the 50-day (simple) moving average. However, I did not find a definition of "buy range" or "buy zone," or what the graphs' blue line is.
  • Hi @Tony
    You noted: " However, I did not find a definition of "buy range" or "buy zone," or what the graphs' blue line is."
    Agree.
    I did enlarge (bottom right corner, 4 diagonal arrows) the graphic and found the blue line is relative strength vs SP500.

    Another chart view (3 year), of which; you have already viewed in one fashion or another.

    http://stockcharts.com/h-sc/ui?s=IBB&p=W&yr=3&mn=0&dy=0&id=p86325357921
Sign In or Register to comment.